Trial Outcomes & Findings for Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors (NCT NCT06053268)
NCT ID: NCT06053268
Last Updated: 2026-07-23
Results Overview
Mindfulness app adherence was defined as the proportion of participants who completed at least 4 meditation sessions on average during the 30-day intervention.
ACTIVE_NOT_RECRUITING
NA
50 participants
30 days (during intervention)
2026-07-23
Participant Flow
Recruitment occurred 5/23/24-2/4/25. Potential participants were identified by St. Jude Life and provided to the psychology study team. The participants' medical records were reviewed in Epic to assess eligibility. Eligible participants were contacted via email, followed by a phone call. Upon contact, participants were screened for remaining criteria following an Institutional Review Board (IRB) approved script.
After completing consent, participants had a 7-day wash-out period in which they wore the Empatica Embrace Plus smartwatch to establish a baseline. Intervention started after the 7-day wash-out was complete.
Participant milestones
| Measure |
Single-arm, Within-subject Pilot: EmbracePlus Smartwatch
7-day washout, option dry blood spot sample, baseline surveys, 4 week intervention of 10 minutes of guided meditation through the Headspace app, ecological momentary assessments (EMA) 3x/day for week 1 and 4 of intervention, followed by post intervention surveys, and optional dry blood spot sample.
Headspace: The intervention will be delivered via the Headspace mobile application. The basic application program includes daily 10-minute sessions in guided mindfulness meditation that include mindful breathing, body awareness, emotion and thought recognition, and attentional control
|
|---|---|
|
Initiated Baseline (Consented)
STARTED
|
50
|
|
Initiated Baseline (Consented)
COMPLETED
|
45
|
|
Initiated Baseline (Consented)
NOT COMPLETED
|
5
|
|
Initiated Intervention
STARTED
|
45
|
|
Initiated Intervention
COMPLETED
|
45
|
|
Initiated Intervention
NOT COMPLETED
|
0
|
|
Initiated Post
STARTED
|
45
|
|
Initiated Post
COMPLETED
|
41
|
|
Initiated Post
NOT COMPLETED
|
4
|
Reasons for withdrawal
| Measure |
Single-arm, Within-subject Pilot: EmbracePlus Smartwatch
7-day washout, option dry blood spot sample, baseline surveys, 4 week intervention of 10 minutes of guided meditation through the Headspace app, ecological momentary assessments (EMA) 3x/day for week 1 and 4 of intervention, followed by post intervention surveys, and optional dry blood spot sample.
Headspace: The intervention will be delivered via the Headspace mobile application. The basic application program includes daily 10-minute sessions in guided mindfulness meditation that include mindful breathing, body awareness, emotion and thought recognition, and attentional control
|
|---|---|
|
Initiated Baseline (Consented)
Withdrawal by Subject
|
1
|
|
Initiated Baseline (Consented)
Lost to Follow-up
|
4
|
|
Initiated Post
Withdrawal by Subject
|
1
|
|
Initiated Post
Lost to Follow-up
|
3
|
Baseline Characteristics
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors
Baseline characteristics by cohort
| Measure |
Single-arm, Within-subject Pilot
n=50 Participants
This is a single arm, within subject feasibility pilot; all participants received the same mindfulness intervention
|
|---|---|
|
Age, Continuous
|
28.36 Years
STANDARD_DEVIATION 5.45 • n=9 Participants
|
|
Sex/Gender, Customized
Male
|
17 Participants
n=9 Participants
|
|
Sex/Gender, Customized
Female
|
32 Participants
n=9 Participants
|
|
Sex/Gender, Customized
Non-binary
|
1 Participants
n=9 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
7 Participants
n=9 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic Black
|
13 Participants
n=9 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic White
|
27 Participants
n=9 Participants
|
|
Race/Ethnicity, Customized
Other
|
3 Participants
n=9 Participants
|
|
Region of Enrollment
United States
|
50 Participants
n=9 Participants
|
PRIMARY outcome
Timeframe: 30 days (during intervention)Mindfulness app adherence was defined as the proportion of participants who completed at least 4 meditation sessions on average during the 30-day intervention.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=45 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Mindfulness App Adherence
|
37 Participants
|
PRIMARY outcome
Timeframe: Up to 1 week post interventionPopulation: n=41 with completed post-intervention assessment data
Treatment Acceptability and Adherence Scale - Participants will rate on a 0 ("Strongly disagree") to 7 ("Strongly agree") scale regarding their perceptions of acceptability of the mindfulness intervention (10 items). Scores range from 0-70. An overall score is provided with higher scores indicating higher intervention acceptability.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=41 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Intervention Acceptability
|
51.95 Total score
Standard Deviation 8.52
|
PRIMARY outcome
Timeframe: Up to 1 week post interventionPopulation: n=41 with completed post-intervention assessment data
An adapted version of the Treatment Acceptability and Adherence Scale was created to evaluate ecological momentary assessment acceptability (7 items). Scores range from 0-49. An overall score is provided with higher scores indicating higher intervention acceptability.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=41 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Ecological Momentary Assessment Data Collection Acceptability
|
28.49 Total score
Standard Deviation 4.69
|
PRIMARY outcome
Timeframe: Approximately 37 days over the study window (7-day baseline washout plus 30-day intervention)Population: n=45 with post-intervention biosensor data
Biosensor adherence was defined as the proportion of participants who wore the wrist-worn biosensor for at least 10 hours per day across the approximately 37-day study window.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=45 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Biosensor (Wrist-worn Device) Adherence
|
36 Participants
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionPopulation: n=41 participants with completed post-intervention assessment data
This measure is a 10-item, widely used and validated assessment of stress and efficacy of managing stress. The Participants are asked to respond to each question on a 5-point Likert scale ranging from 0 (never) to 4 (very often), indicating how often they have felt or thought a certain way within the past month. A single score is provided and ranges from 0 to 40. Higher scores indicate higher levels of stress.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=41 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Perceived Stress Scale
Baseline
|
23.17 Score
Standard Deviation 3.83
|
|
Perceived Stress Scale
1 Week Post Intervention
|
23.32 Score
Standard Deviation 2.94
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionPopulation: n=41 participants with completed post-intervention assessment data
The Brief COPE is a validated measure of coping strategies. Six subscales were included in this analysis: behavioral disengagement, planning, positive reframing, meditation/religious coping, self-blame, and emotional support. Participants rated each item on a 4-point Likert scale, and subscale scores range from 2 to 8 for each domain, with higher scores indicating greater use of the given coping strategy. Higher scores are not uniformly better or worse outcomes because interpretation depends on the coping strategy; for example, higher planning, positive reframing, and emotional support generally reflect greater use of adaptive coping strategies, whereas higher behavioral disengagement and self-blame reflect greater use of maladaptive coping strategies.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=41 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Brief Coping Orientation to Problems Experienced (COPE)
Baseline: Behavioral Disengagement
|
3.15 Score
Standard Deviation 1.31
|
|
Brief Coping Orientation to Problems Experienced (COPE)
Baseline: Planning
|
5.80 Score
Standard Deviation 1.60
|
|
Brief Coping Orientation to Problems Experienced (COPE)
Baseline: Positive Reframing
|
4.78 Score
Standard Deviation 1.90
|
|
Brief Coping Orientation to Problems Experienced (COPE)
Baseline: Meditation/Religious Coping
|
4.33 Score
Standard Deviation 2.13
|
|
Brief Coping Orientation to Problems Experienced (COPE)
Baseline: Self-Blame
|
5.29 Score
Standard Deviation 1.85
|
|
Brief Coping Orientation to Problems Experienced (COPE)
Baseline: Emotional Support
|
4.51 Score
Standard Deviation 1.70
|
|
Brief Coping Orientation to Problems Experienced (COPE)
1 Week Post Intervention: Behavioral Disengagement
|
3.02 Score
Standard Deviation 1.39
|
|
Brief Coping Orientation to Problems Experienced (COPE)
1 Week Post Intervention: Planning
|
6.24 Score
Standard Deviation 1.45
|
|
Brief Coping Orientation to Problems Experienced (COPE)
1 Week Post Intervention: Positive Reframing
|
5.68 Score
Standard Deviation 1.57
|
|
Brief Coping Orientation to Problems Experienced (COPE)
1 Week Post Intervention: Meditation/Religious Coping
|
5.30 Score
Standard Deviation 1.91
|
|
Brief Coping Orientation to Problems Experienced (COPE)
1 Week Post Intervention: Self-Blame
|
4.93 Score
Standard Deviation 1.81
|
|
Brief Coping Orientation to Problems Experienced (COPE)
1 Week Post Intervention: Emotional Support
|
4.93 Score
Standard Deviation 1.93
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionPopulation: The analysis population included the 32 participants with evaluable dried blood spot specimens at the analyzed time point(s). Dried blood spot collection was optional; therefore, this analytic sample is smaller than the number of participants who initiated or completed study assessments.
Oxidized low-density lipoprotein was measured from dried blood spot specimens as a biomarker of oxidative modification of low-density lipoprotein particles. Values are reported in units per liter. Higher values indicate greater oxidized low-density lipoprotein concentrations.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=32 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Oxidized Low-Density Lipoprotein
Baseline
|
8.33 Units/liter
Standard Deviation 5.95
|
|
Oxidized Low-Density Lipoprotein
1 Week Post Intervention
|
8.26 Units/liter
Standard Deviation 4.85
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionPro-B-type natriuretic peptide was measured from dried blood spot specimens as a biomarker related to cardiac wall stress. Values are reported as log-transformed concentrations in picograms per milliliter (log pg/mL). Higher values indicate higher pro-B-type natriuretic peptide concentrations.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=32 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Pro-B-type Natriuretic Peptide
Baseline
|
4.12 log pg/mL
Standard Deviation 0.99
|
|
Pro-B-type Natriuretic Peptide
1 Week Post Intervention
|
4.17 log pg/mL
Standard Deviation 1.10
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionP-selectin was measured from dried blood spot specimens as a biomarker of platelet activation and vascular inflammation. Values are reported as log-transformed concentrations in picograms per milliliter (log pg/mL). Higher values indicate higher P-selectin concentrations.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=32 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
P-selectin
Baseline
|
6.49 log pg/mL
Standard Deviation 0.49
|
|
P-selectin
1 Week Post Intervention
|
6.62 log pg/mL
Standard Deviation 0.45
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionVascular cell adhesion molecule-1 was measured from dried blood spot specimens as a biomarker of endothelial activation and vascular inflammation. Values are reported in nanograms per milliliter. Higher values indicate higher vascular cell adhesion molecule-1 concentrations.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=32 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Vascular Cell Adhesion Molecule-1
Baseline
|
203.646 nanograms/milliliter
Standard Deviation 58.32
|
|
Vascular Cell Adhesion Molecule-1
1 Week Post Intervention
|
183.79 nanograms/milliliter
Standard Deviation 49.49
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionHomocysteine was measured from dried blood spot specimens as a biomarker related to vascular and cardiometabolic risk. Values are reported in micromoles per liter. Higher values indicate higher homocysteine concentrations.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=32 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
Homocysteine
Baseline
|
9.04 micromoles/liter
Standard Deviation 2.34
|
|
Homocysteine
1 Week Post Intervention
|
8.37 micromoles/liter
Standard Deviation 2.21
|
SECONDARY outcome
Timeframe: Baseline and up to 1 week post interventionHigh-sensitivity C-reactive protein was measured from dried blood spot specimens as a biomarker of systemic inflammation. Values are reported in milligrams per liter. Higher values indicate higher systemic inflammation.
Outcome measures
| Measure |
Single-arm, Within-subject Pilot
n=32 Participants
This is a single-arm, within subject feasibility pilot; all participants received the same mindfulness intervention. Therefore, outcomes are provided for a single group.
|
|---|---|
|
High-sensitivity C-Reactive Protein
Baseline
|
0.23 milligrams/liter
Standard Deviation 0.33
|
|
High-sensitivity C-Reactive Protein
1 Week Post Intervention
|
0.13 milligrams/liter
Standard Deviation 0.20
|
Adverse Events
Single-arm, Within-subject Pilot
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Rachel Webster, PhD
St. Jude Children's Research Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place